We encourage inward investment from life science organisations, that help keep the NHS at the forefront of international health technology research.
Carers and clinicians in todays NHS desire to use the very best advances in medical technology to provide consistently high clinical outcomes and the most safe and effective treatments for their patients. NHS Hospitals need to be as productive as possible to ensure that they are able to treat efficiently and cost effectively. Every day Medical Technology companies across the world are designing breakthrough innovative treatments who desire to introduce them to the NHS. The Device Access team have years of experience in brokering relationships between both. We start by thoroughly understanding the impact new treatments bring by analysing the existing care and treatment pathways, and only help companies that can provide real benefits to patients and the NHS system.
The National Institute for Health and Care Excellence (NICE) is recognised as the World’s Leading HTA. NICE provides national guidance and advice to improve health and social care. NICE guidance protects patients’ safety and supports people in the NHS so that it is possible for new treatments and tests to be introduced into the NHS in a responsible way. Many of the procedures that NICE investigates are new, but NICE also looks at more established procedures if there is uncertainty about their safety or how well they work.
Every year, the Device Access team assists credible Innovative Medical Technology providers successfully navigate NICE Medical Technology and Diagnostic evaluation programmes, leading to NHS adoption and diffusion of new breakthrough technologies for the benefits of its patients.
The National Institute for Health Research (NIHR) fund health and care research and translate discoveries into practical products, treatments, devices and procedures, involving patients, charities and the public in their work. The NIHR ensures the NHS is able to support the research of other funders to encourage broader investment in, and economic growth from health research, and helps keep the nation at the forefront of international research.
Device Access works collaboratively with the NIHR Office for Clinical Research Infrastructure (NOCRI), who support the life sciences industry navigate the NIHR infrastructure to form research partnerships and collaborations, to help bring new breakthrough treatments to patients faster.
How We Help
Device Access will introduce you to the research bodies and key opinion leaders of the NHS, assisting you through the process of developing clinical evidence for a submission to NICE (National Institute for Health & Care Excellence). We assist many MedTech and Diagnostic Companies in successful engagement within the new NICE MedTech programmes which have led to Technology Appraisal (TA) Interventional Procedures (IP) Diagnostic Appraisal Programme (DAP) and MedTech (MTG) guidance. And we’ll provide you with the sales and economic tools to engage with clinical and non-clinical stake-holders.
Device Access will introduce you to the research bodies and key opinion leaders of the NHS, assisting you through the process of developing clinical evidence for a submission to NICE (National Institute for Health & Care Excellence).
And we'll provide you with the sales and economic tools to engage with clinical and non-clinical stake-holders.
We are governed and approved under the NHS Information and Governance (IG) toolkit and a member of the Information Commissioners Office (ICO) for Data Protection.
Device Access UK granted access to NHS activity data
20th Jan 2015 - Health and Social Care Information Centre (HSCIC) grants Device Access UK Ltd the licence to access anonymised National Health Service (NHS) England patient data – giving Device Access a greater opportunity to analyse patient pathways.
Device Access UK Ltd (Michelmersh, Romsey UK) NHS Market Access and Reimbursement Consultancy for Medical Devices and Diagnostics, is delighted to announce that it has been granted a licence to access NHS patient data stored by the Health and Social Care Information Centre (HSCIC) – the National provider of information, data and IT systems for commissioners, analysts and clinicians in health and social care
Michael Branagan-Harris, Device Access’s CEO, says: “The award of this licence is a significant milestone for our clients and helps demonstrate a close working relationship with NHS bodies developed over almost 5 years.
“Our services include helping National and International clients take Medical technological devices and diagnostics to the NHS through the National Institute for Health and Care Excellence (NICE) Medical Technologies Evaluation Programmes (MTEP), for discussions around the introduction, evaluation and adoption of these technologies. The next step with NICE is a formal submission for them to ultimately consider issuing guidance on the new technology use in the NHS. As part of this process it is vitally important for our clients to be able to demonstrate and identify clear improvements to patient treatment, including diagnosis, admission, interventions performed and hospital stay; thus highlighting the benefit of technology adoption to patients, hospitals and the NHS. We are now able to offer this invaluable service to support these applications.
Richard Tuson, Device Access’s Health Analytics and Policy Specialist, adds: “We can use this data to conduct analysis to identify within every health economy, (including hospitals and Clinical Commissioning Group areas), where medical technological devices can be used by NHS providers in patient care pathways to improve patient outcomes and reduce the length of stay; patient waiting times and diagnostic waiting times. This all helps to drive efficiency in the NHS.
